Evidence map›Paper›PMID 29785016›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2018

Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.

Nadjla Alsadoun, Gaëtan MacGrogan, Caroline Truntzer, Magali Lacroix-Triki, Isabelle Bedgedjian, Marie-Hélène Koeb, Elsy El Alam, Dan Medioni, Michel Parent, Pascal Wuithier and 3 more

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 64 citations in OpenAlex.

  1. [An unusual mass in the breast].Radiologie (Heidelberg, Germany) · 2026
    Article
  2. Article
  3. Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection ofInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Metastasis ofFrontiers in oncology · 2025
    Article
  8. Review
  9. Molecular Basis of Breast Tumor Heterogeneity.Advances in experimental medicine and biology · 2025
    Review
  10. Targeting low-risk triple-negative breast cancer: a review on de-escalation strategies for a new era.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Codon 172 in theGland surgery · 2022
    Article
  18. Article
  19. Papillary lesions of the breast.Virchows Archiv : an international journal of pathology · 2022
    Review
  20. Breast carcinomas of low malignant potential.Virchows Archiv : an international journal of pathology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Nadjla AlsadounDépartement de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France. nadjla.alsadoun@gmail.com.
Gaëtan MacGroganDépartement de Biopathologie, Institut Bergonié, 229 cours de l'Argonne, 33076, Bordeaux, France.
Caroline TruntzerDépartement de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France.
Magali Lacroix-TrikiDépartement de Pathologie, Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Isabelle BedgedjianService d'Anatomie et Cytologie Pathologiques, Centre Hospitalier Universitaire de Besançon, 25030, Besançon Cedex, France.
Marie-Hélène KoebCypath Lyon, 201 route de Genas, 69100, Villeurbanne, France.
Elsy El AlamDépartement de Pathologie, Institut Curie, Saint Cloud, 35 rue Dailly, 92210, Saint Cloud, France.
Dan MedioniMedipath Cannes-Antibes-Grasse, 80 allée des ormes, 06250, Mougins, France.
Michel ParentPathologie Nord Unilabs, 60 boulevard Jean Baptiste Lebas, 59000, Lille, France.
Pascal WuithierCentre de Pathologie, 13 rue Carnot, 65000, Tarbes, France.
Isabelle RobertAtalante Pathologie, 10 rue J-Louis Bertrand -BP11633, 35016, Rennes cedex, France.
Romain BoidotDépartement de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France.
Laurent ArnouldDépartement de Biologie et Pathologie des Tumeurs, Centre Georges-François Leclerc - Unicancer, 1 rue Professeur Marion, 21000, Dijon, France.
Centre Georges François Leclerc · FRCentre Hospitalier de Bigorre · FRCentre Hospitalier de Cannes · FRCentre Hospitalier Universitaire de Besançon · FRInstitut Bergonié · FRInstitut Bouisson Bertrand · FRInstitut Curie · FRInstitut Gustave Roussy · FRUniversité Lille Nord de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid papillary carcinoma with reverse polarity is a rare breast cancer of favorable prognosis that can be difficult to diagnose. We report here nine additional cases of this tumor, and we describe its morphologic, immunohistochemical and molecular profile in comparison to other types of papillary and micropapillary lesions of the breast that are intraductal papilloma with usual ductal hyperplasia, encapsulated papillary carcinoma, solid papillary carcinoma and invasive micropapillary carcinoma. We studied nine cases of this special papillary tumor and six of each other types mentioned above. We found that solid papillary carcinoma with reverse polarity harbor specific morphologic features as cuboid or tall cells with abundant eosinophilic cytoplasms located at the basal pole giving the impression of reverse nuclear polarity. Nuclei were sometimes grooved. Immunohistochemistry demonstrated the lack of myoepithelial cells, as in encapsulated papillary carcinoma and solid papillary carcinoma, questioning their invasive nature. Seven of nine solid papillary carcinoma with reverse polarity showed a low Ki67 proliferative index (Ki67 <5%). They showed expression of CK5/6 as in intraductal papilloma with usual ductal hyperplasia. They showed expression of calretinin and a low or lack of hormonal receptor (HR) expression that were not observed in other breast tumors studied. By whole-exome analysis, seven of nine solid papillary carcinomas with reverse polarity (78%) harbored a hotspot mutation in IDH2 (R172) that was totally absent in other groups. Six of nine tumors (67%) also harbored PRUNE2 mutation, including the two IDH2 wild-type cases. We also demonstrated for the first time in this breast tumor, immunostaining with a specific antibody IDH1/2 mutant R132/R172 (7/9) that can highlight IDH2 mutation. Moreover, transcriptomic analysis showed that proteoglycan pathway was significantly enriched. Our findings support the fact that solid papillary carcinoma with reverse polarity is a singular breast neoplasm that can be distinguished from other papillary breast tumors.

Indexed as

MutationAgedBiomarkers, TumorBreastBreast NeoplasmsCarcinoma, PapillaryCell ProliferationFemaleGene Expression ProfilingHumansImmunohistochemistryIsocitrate DehydrogenaseMiddle AgedBiomarkers, TumorIDH2 protein, humanIsocitrate Dehydrogenase

Identifiers

PMID29785016
OpenAlexW2804253441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.